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rected by bicarbonate and completely corrected by pancreatic proteases but the mechanisms involved are unknown. Because saliva contains enough R-type Cblbinding protein (R protein) to bind all of the dietary and biliary Cbl, it is possible that R protein acts as an inhibitor of Cbl absorption and that pancreatic proteases are required to alter R protein and prevent such inhibition. To test this hypothesis we studied the ability of R protein and intrinsic factor (IF) to compete for Cbl binding and ability of pancreatic proteases to alter this competition.
Human salivary R protein bound Cbl with affinities that were 50-and 3-fold higher than those of human IF at pH 2 (1) (2) (3) (4) and in some cases actually develop Cbl deficiency (5) . The malabsorption can be partially corrected with oral bicarbonate (2, 6) and completely corrected with oral pancreatic extract (2, 4, 6, 7), trypsin (7, 8) , or chymotrypsin (8) but the mechanisms involved have not been defined.
Determinations of ileal pH have found values near neutrality in patients with pancreatic insufficiency and differences have not been observed between those with normal and those with abnormal Cbl absorption (3) . These observations, together with the fully corrective effects of pancreatic proteases, rule out the unlikely possibility that the primary defect in those patients with Cbl malabsorption is an inability of the pancreas to secrete enough bicarbonate to neutralize gastric HC1 and raise the ileal pH to values (pH 5.6-10) that will enable intrinsic factor (IF)-Cbl to bind to its ileal receptors.
Studies in patients have shown that IF is produced in normal amounts (3) and that this IF functions normally in terms of correcting Cbl malabsorption in patients with pernicious anemia (2) . Studies in partially pancreatectomized rats (9) have shown that ileal receptors for IF-Cbl are present in normal amounts and that they function normally in terms of binding the IF-Cbl complex. Cbl malabsorption in humans with pancreatic insufficiency is not corrected by the oral administration of antibiotics nor is it corrected by binding Cbl to human gastric juice or crude hog IF in vitro and then administering it either orally or in the latter case directly into the distal ileum (3).
Toskes et al. (8) have shown that Cbl is absorbed normally in pancreatic insufficiency when it is given bound to human gastric juice or crude hog IF that have been incubated previously with insolubilized trypsin or chymotrypsin. This has suggested that pancreatic proteases might alter the structure of IF and that this might be required for IF to facilitate the actual absorption of Cbl. Attempts to demonstrate that pancreatic proteases do alter the structure of IF in terms of its molecular weight, electrophoretic mobility, or affinity for Cbl have, however, been unsuccessful (8) .
It has also been suggested (4, 8, (10) (11) (12) (13) ) that pancreatic proteases might inactivate an endogenous inhibitor of Cbl absorption and several investigators (10) (11) (12) (13) have suggested that the R-type Cbl-binding protein2 (R protein) might act as such an inhibitor. This possibility is supported by the presence of R protein in saliva, milk, gastric juice, bile, and crude hog IF (14, 15) and by the fact that the 25 nmol/24 h of R protein in saliva alone (16, 17) is capable ofbinding all ofthe Cbl present in a normal diet (4-12 nmol/24 h) and in bile (2-6 nmol/ 24 h) (14) . Because little is known about the abilities of METHODS Cbl-binding proteins and antisera. Human gastric juice was collected as described previously (18) and 10 ml was applied to a 2 x 90-cm column of Sephadex G-150 (Sigma Chemical Co., St. Louis, Mo.) equilibrate at 4°C with 0.01 M Tris-HCl, pH 8.0, containing 0.15 M NaCl and 50 ug/ml of bovine serum albumin (Sigma Chemical Co.). 5-ml fractions were collected and assayed for total Cbl-binding ability (18) and Cbl-binding ability due to IF (18 (16) and labeled with 1251 and "3Il by the method of Bolton and Hunter (19) as previously described (20) . Rabbit anti-human IF (21) and anti-human R protein (16) sera were obtained as previously described. Association constants for Cbl-binding proteins and Cbl were determined at 37°C in standard incubation buffer using the charcoal adsorption technique as described (22 The ability of pancreatic proteolytic enzymes to alter the distribution and transfer of [57Co]Cbl between R protein and IF was studied by performing a 60-min preliminary incubation at 37°C with enzyme and various components of the standard assay. This was followed by the addition of 1 ,ul (5.5 mmol) of diisopropyl fluorophosphate (DFP) (Sigma Chemical Co.) and after 15 min at 37°C the remaining components of the assay were added.
Studies performed at acid pH employed 0.01 M potassium phosphate pH 2.0 in place of Tris-HCl. The volume of the initial incubation was reduced to 450 and 50 ,ul of 0.5 M Tris base was added to bring the pH to 8.0 immediately before the addition of rabbit antiserum.
Proteolytic enzymes, inhibitors, and assays. Bovine pan-creatic trypsin, trypsin treated with L-1-tosylamide-2-phenylethylchloromethyl ketone (TPCK), (TPCK-trypsin), and bovine pancreatic a-chymotrypsin were obtained from Worth- curred at a total protein concentration of only 4 ug/ml which indicates that levels of these enzymes well within the physiologic range (26) at pH 8 nor that orally administered Cbl, and even Cbl bound to IF, 4, R protein, would be bound almost exclusively by R protein in the )00 ,ug/ml of stomach under normal conditions of acid pH. It also appears that Cbl would remain bound to R protein zymes cause at the nearly neutral pH of the small intestine and from experi-would not become bound to IF until the R protein gel filtration moiety is partially degraded by the pancreatic serine protein with proteases, trypsin and chymotrypsin, which act synhown in Fig. ergistically 
